Halting the development of leukemia cells, demonstrating the potential viability of RUNX1 as a therapeutic target

New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML). Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online by the journal. The protein scientists targeted is a transcription factor known as RUNX1, which also plays an important role in helping regulate the normal development of blood cells... via Health News from Medical News Today Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/08/halting-development-of-leukemia-cells.html